Adrenal News

Patients who have undergone surgery to remove a pheochromocytoma or paraganglioma should be followed for at least 10 years to assess for local or metastatic tumor recurrence, according to a new clinical practice guideline released by the European Society of Endocrinology.

BOSTON — In this video exclusive, Barbara A. Cohn, PhD, director of the Child Health and Development Studies at the Public Health Institute, discusses her presentation on endocrine disrupting chemicals and multigenerational health consequences.

BOSTON — Maria Fleseriu, MD, FACE, professor of medicine and neurologic surgery at Oregon Health Sciences University, discusses her presentation on Cushing’s disease and treatment selection.

BOSTON — In this video exclusive, Hershel Raff, PhD, professor of medicine, surgery and physiology at the Medical College of Wisconsin and scientific director and clinical research supervisor at Aurora St. Luke’s Medical Center, discusses his presentation on the laboratory diagnosis of Cushing’s syndrome.

BOSTON — Constantine A. Stratakis, MD, a senior investigator and head of the section on genetics and endocrinology at the Eunice Kennedy Shrive National Institute of Child Health and Human Development, discusses his presentation on the genetic defects that affect adrenal development.

BOSTON — At least some patients with primary aldosteronism can avoid adrenal venous sampling for determining the laterality of aldosterone excess, according to study data presented here.

BOSTON — A high prevalence of pituitary hormone deficiencies has been found among Veterans who sustain mild traumatic brain injury, according to data presented here.

BOSTON — Molecular testing served as a useful tool in identifying false-positive results for congenital adrenal hyperplasia in newborns in Brazil, helping to prevent unnecessary follow-up testing after inconclusive results, according to study findings presented here.

BOSTON — A new assay that can quantify anti-Mullerian hormone in pg/mL may help clinicians predict bone loss in women undergoing menopause, according to a presenter here.

A quick cortisol assay using immunochromatography and gold nanoparticles can accurately determine plasma cortisol levels within 6 minutes without additional technical assistance, improving the rate of success in identifying adults with primary aldosteronism, according to results from single-center and multicenter studies.